GGrantIndex
← Leaderboards

Wenjian Gan

Beth Israel Deaconess Medical Center

$3,628,577
Attributed
$3,628,577
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $737.9K · FY201625
$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,628,577 · 4

By mechanism

R35$1,525,000 · 1
R01$1,018,969 · 1
R00$747,000 · 1
K99$337,608 · 1

Top collaborators

No co-investigators on record.

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingMolecularMouse ModelBreast Cancer PatientAmericanCancer DiagnosisWomanOncogenicGeneticTherapy ResistantCancer EtiologyBiological ProcessMalignant Breast NeoplasmResistanceXenograft ProcedureCessation Of LifeCell Culture TechniquesBreast Cancer CellBreast Cancer Cell LineBiochemistryPlayBindingReaderMalignant Neoplasms

Grant awards (13)

Regulatory Mechanisms of Arginine Methylation$392,500
R35 · FY2025 · GM · contact PI
Characterizing and targeting PRMT5 in autophagy for cancer treatment$345,412
R01 · FY2025 · CA · contact PI
Characterizing and targeting PRMT5 in autophagy for cancer treatment$1
R01 · FY2025 · CA · contact PI
Regulatory Mechanisms of Arginine Methylation$377,500
R35 · FY2024 · GM · contact PI
Characterizing and targeting PRMT5 in autophagy for cancer treatment$328,143
R01 · FY2024 · CA · contact PI
Regulatory Mechanisms of Arginine Methylation$377,500
R35 · FY2023 · GM · contact PI
Characterizing and targeting PRMT5 in autophagy for cancer treatment$345,413
R01 · FY2023 · CA · contact PI
Regulatory Mechanisms of Arginine Methylation$377,500
R35 · FY2022 · GM · contact PI
Elucidating Novel Akt Regulatory Mechanisms to Overcome Akt-mediated Therapeutic Resistance in Breast Cancer$249,000
R00 · FY2021 · CA · contact PI
Elucidating Novel Akt Regulatory Mechanisms to Overcome Akt-mediated Therapeutic Resistance in Breast Cancer$249,000
R00 · FY2020 · CA · contact PI
Elucidating Novel Akt Regulatory Mechanisms to Overcome Akt-mediated Therapeutic Resistance in Breast Cancer$249,000
R00 · FY2019 · CA · contact PI
Elucidating Novel Akt Regulatory Mechanisms to Overcome Akt-mediated Therapeutic Resistance in Breast Cancer$168,804
K99 · FY2017 · CA · contact PI
Elucidating Novel Akt Regulatory Mechanisms to Overcome Akt-mediated Therapeutic Resistance in Breast Cancer$168,804
K99 · FY2016 · CA · contact PI